Clinical Trials Decriminalization Events Policy 
SpeedWeed
JULY 6, 2021
Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . Harvard’s new center will be the first to focus solely on psychedelics policy and laws rather than research, though. View original article.
Cannabis Law Report
JULY 1, 2021
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Here’s the press release. The Project on Psychedelics Law and Regulation (POPLAR).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
FEBRUARY 10, 2022
Psilocybin’s therapeutic benefits are so promising that Denver, Colorado became the first city to decriminalize psilocybin in May 2019, and in 2020, Oregon passed Measure 109, which paved the road for a program allowing for legal manufacture, delivery, and administration of psilocybin to clients at supervised, licensed facilities in the state.
The Cannigma
MAY 19, 2021
Japan has some of the harshest drug policies on Earth, including for cannabis — and is one of the worst places on Earth to get arrested on marijuana possession charges. The Tokyo Marijuana March has been held since 2001, though it’s a much more reserved and smoke-free event than its counterparts in many other countries.
Cannabis Law Report
SEPTEMBER 14, 2021
13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.
The Cannigma
MAY 7, 2021
Now, that’s going to matter significantly when as we advance clinical trials, as we advance product formulation as not just product formulation within pharma but all product formulation and that comes down to the initial process in relation to the supply chain of pretty hardcore standardization. MSO: Let’s pivot for a minute.
Cannabis Law Report
DECEMBER 30, 2019
After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019. Erik Altieri.
Expert insights. Personalized for you.
52 
Let's personalize your content